Patents Assigned to Fondazione IRCCS “Istituto Nazionale Dei Tumori”
  • 4-oxo-fenretinide, administered alone and in combination with fenretinide, as preventive and therapeutic agent for cancer
    Patent number: 7169813
    Abstract: A drug based on a metabolite of fenretinide, or N-(4hydroxyphenyl) retinamide (4-HPR), specifically 4-oxo-N-(4-hydroxyphenyl) retinamide (4-oxo-4-HPR), is used in the treatment of different kinds of tumors, in particular in the treatment of ovarian carcinoma, breast tumor and neuroblastoma. The drug is more potent than fenretinide alone, and enhances the effects of fenretinide when administered together with fenretinide.
    Type: Grant
    Filed: March 18, 2004
    Date of Patent: January 30, 2007
    Assignee: Fondazione IRCCS “Istituto Nazionale Dei Tumori”
    Inventor: Franca Formelli